跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEPAKINE 400MG-4ML Powder for injection - SFDA Drug Approval Details
Approvals
/
SFDA
/
DEPAKINE 400MG-4ML Powder for injection
Authorized
NCE
DEPAKINE 400MG-4ML Powder for injection
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
97a0c36a0a2d0b09
Company
Unknown
Type
NCE
Approval Details
Approval Id
97a0c36a0a2d0b09
Drug Approval Sfda Name
DEPAKINE 400MG-4ML Powder for injection
Trade Name
DEPAKINE 400MG-4ML Powder for injection
Generic Name
VALPROATE SODIUM
Register Number
30-883-20
Register Year
2020
Drug Type
NCE
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
4
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000001304-100-100000073868
Price
128.35
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
97a0c36a0a2d0b09
Type
NCE
Back to SFDA Approvals